Culture of ‘bending rules’ in India challenges U.S. drug agency

The FDA didn’t comment specifically on the reports but cautioned that they don’t all indicate a causal relationship to the drug.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2UtRVEA
via IFTTT